Rahlfs Capital
ABBV icon

Rahlfs Capital’s AbbVie ABBV Stock Holding History

Rahlfs Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.54M Hold
5,899
– – 1.03% 28
2026
Q2 		$1.48M Sell
5,899
-500
-8% -$108K 1.09% 27
2026
Q1 		$1.39M Sell
6,399
-550
-8% -$122K 1.02% 32
2025
Q4 		$1.59M Sell
6,949
-63
-0.9% -$14.4K 1.23% 25
2025
Q3 		$1.62M Hold
7,012
– – 1.28% 23
2025
Q2 		$1.3M Sell
7,012
-500
-7% -$92.9K 1.19% 25
2025
Q1 		$1.57M Hold
7,512
– – 1.58% 19
2024
Q4 		$1.33M Buy
+7,512
New +$1.38M 1.32% 21

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Rahlfs Capital's ABBV Position: Q3 2026 in Review

Rahlfs Capital held its AbbVie (ABBV) position steady in Q3 2026 at 5,899 shares worth $1.54M. The position accounts for 1.03% of the portfolio, ranked #28.

Rahlfs Capital first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q3 2025. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Rahlfs Capital held 5,899 shares of AbbVie worth $1.54M as of Q3 2026.
  • Rahlfs Capital left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 1.03% of Rahlfs Capital's portfolio in Q3 2026, its #28 holding.
  • Rahlfs Capital first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • Rahlfs Capital's AbbVie position peaked at $1.62M in Q3 2025.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Rahlfs Capital's 13F filing for Q3 2026, filed 23 Oct 2026.